Loftware and Signant Health have introduced an integrated solution intended to expedite clinical supply chain management, connecting Loftware Cloud Clinical Trials with Signant Health’s GxP Inventory Clinical Supplies Management platform. The integration automates critical processes, including the seamless transfer of clinical trial master data, direct print requests, and real-time print status updates, significantly enhancing efficiency and accuracy. By addressing the complexities of direct-to-site and direct-to-patient supply models, the solution enables pharmaceutical companies to meet the growing demands of global clinical trials with agility and compliance.
Loftware, a leader in enterprise labeling and artwork management solutions, supports over 51 billion label prints annually with its end-to-end cloud-based labeling platform. The company helps businesses across diverse industries enhance traceability, accuracy, and regulatory compliance while preventing fines. With a global presence and expertise spanning decades, Loftware is a trusted partner for leading enterprises. Signant Health, an expert in evidence-generation for contemporary clinical trials, has supported more than 600 sponsors and CROs, including the top 20 pharmaceutical companies. Its advanced solutions facilitate traditional, hybrid, and virtual clinical trials, ensuring high-quality evidence through advanced supply chain management and data analytics.
